Glennon Simmons currently leads the McDevitt Group’s engineering team in designing novel fully-integrated lab-on-a-chip devices and in vitro diagnostic tests for heart attack, congestive heart failure, ovarian cancer, prostate cancer, oral cancer, and roadside drug testing. The PBNC assay system was featured as one of 12 finalist technologies in The Nokia Sensing Xchallenge (October 2013), a global competition to demonstrate potential breakthroughs in health sensing technology. |